Literature DB >> 25161954

Acquired iris inclusion cysts.

Aruna Dharmasena1, Priya Bhatt1, Jeffrey Kwartz1.   

Abstract

Year:  2014        PMID： 25161954      PMCID： PMC4137218          DOI： 10.3980/j.issn.2222-3959.2014.04.29

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  7 in total

1.  Usefulness of two-stage ethanol ablation in the treatment of benign predominantly cystic thyroid nodules.

Authors:  Dong Wook Kim
Journal:  Endocr Pract       Date:  2014-06       Impact factor: 3.443

2.  Long-term follow-up and visual outcome after excision of a traumatic iris cyst by viscoelastic dissection.

Authors:  Huda Al-Ghadeer; Abdul Elah Al-Towerki; Ali Al-Rajhi; Abdulaziz Al-Awad
Journal:  Int Ophthalmol       Date:  2012-01-06       Impact factor: 2.031

3.  Surgical management of anterior chamber epithelial cysts.

Authors:  Julia A Haller; Walter J Stark; Amr Azab; Robert W Thomsen; John D Gottsch
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

4.  Epithelial iris cyst treatment with intracystic ethanol irrigation.

Authors:  Zohreh Behrouzi; Aliasghar Khodadoust
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

5.  Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model.

Authors:  William Mol; Hiroshi Furukawa; Satoru Sasaki; Utano Tomaru; Toshihiko Hayashi; Akira Saito; Munetomo Nagao; Noriko Saito; Shinya Hata; Yuhei Yamamoto
Journal:  Dermatol Surg       Date:  2007-12       Impact factor: 3.398

6.  Surgical approaches to the management of epithelial cysts.

Authors:  Julia A Haller; Walter J Stark; Amar Azab; Robert W Thomsen; John D Gottsch
Journal:  Trans Am Ophthalmol Soc       Date:  2002

7.  Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children.

Authors:  Jing Zhang; Hai-Bo Li; Shao-Yi Zhou; Kun-Shan Chen; Chuan-Qiang Niu; Xiao-Yun Tan; Yi-Zhou Jiang; Que-Qing Lin
Journal:  Exp Ther Med       Date:  2013-06-05       Impact factor: 2.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.